Back

Biomarker-based clinical evaluation in ATTR-CM: plasma fibroblast-growth-factor-23 assessment

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Molecular mechanisms in heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Mahshid Eslami

Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
Gut barrier disruption deteriorates HFpEF
Assistant Professor J. Wang (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Low-valine diet ameliorates pathological cardiac hypertrophy by inhibiting LONP1-mediated ATP5F1B degradation
Doctor H. Kuang (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
The role of sex hormones in Takotsubo syndrome: a preclinical investigation
Mr E. Zulfaj (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Altered arginin-vasopressin (AVP)/apelin system balance in congestive heart failure patients under diuretic resistance: results from a pilot study
Doctor A. Bongrani (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Optimizing endothelial function: a pathway to improved cardiac performance in heart failure
Associate Professor S. Charfeddine (Sfax, TN)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular mechanisms in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Fibroblast growth factor 23 is a strong independent marker of poor outcome after an acute coronary syndrome
thumbnail
Congress Presentation
Comparative characteristics of patients with cardiac amyloidosis with and without monoclonal gammopathy in the TTRACK study population
thumbnail
Congress Presentation
True prevalence of transthyretin cardiac amyloidosis in an unselected heart failure with preserved ejection fraction cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources